Discover a study regime that included a treatment serum, a redness-reducing moisturizer, and sunscreen that showed promising ...

Treatment with topical ivermectin may improve the symptoms of rosacea through modulation of the skin microbiome beyond decreasing Demodex," the authors concluded. "The results of this study,” they ...

The US’ Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi, the brand name for its 40mg minocycline hydrochloride extended-release capsules, to be used in the treatment ...

Rosacea is thought to affect around 5% of the global population. Credit: Alona Siniehina / Shutterstock. The US’ Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi, the brand ...

Look at these pore souls. Dr. Scott Walter — a board-certified dermatologist in the Denver area — is raising awareness about ...

More than 90% of patients surveyed by the NRS reported lowered self-esteem due to the condition, with 88% of those with severe symptoms noting that rosacea has affected their professional ...

which is also only approved for the treatment of inflammatory lesions in rosacea but has become the standard treatment in the US. Another consideration is that the first generic versions of Oracea ...

(RTTNews) - Journey Medical (DERM) announced the FDA has approved Emrosi for the treatment of inflammatory lesions of rosacea in adults. Emrosi was developed in collaboration with Dr. Reddy's ...

An eye doctor has opened up on finding parasitic eye infections in his patients that he says are commonly caused by one ...